John W. Gillard
Directeur Technique/Scientifique/R&D chez Aegera Therapeutics, Inc.
Provenance du réseau au premier degré de John W. Gillard
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 76 | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
11
| Subsidiary | Biotechnology | 11 |
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies.
8
| Extinct | Pharmaceuticals: Other | 8 |
Canadian Genetics Diseases Network
 Canadian Genetics Diseases Network Miscellaneous Commercial ServicesCommercial Services Canadian Genetics Diseases Network provides research and development services to the healthcare industry. The company is headquartered in Vancouver, Canada.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Kinetek Pharmaceuticals, Inc.
1
| Extinct | Pharmaceuticals: Major | 1 |
GLYCODesign, Inc.
 GLYCODesign, Inc. Pharmaceuticals: MajorHealth Technology GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à John W. Gillard via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| McGill University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin Undergraduate Degree Graduate Degree | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal President Corporate Officer/Principal Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Director/Board Member Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Corporate Officer/Principal Doctorate Degree Director/Board Member Doctorate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Founder Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
| BELLUS HEALTH | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Director of Finance/CFO | |
| RADIUS HEALTH, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| New York University | College/University | Director/Board Member Masters Business Admin Masters Business Admin | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Corporate Officer/Principal | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor Corporate Officer/Principal | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
GeneChem Management, Inc.
 GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Director/Board Member | |
| 9342-8530 QUÉBEC INC. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal Private Equity Investor | |
AgeChem Financial, Inc.
 AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
| Rochester Christian University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Dickinson College | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Corporate Officer/Principal | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MEDMIRA INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| University of Montréal | College/University | Graduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| Université Laval | College/University | Doctorate Degree Undergraduate Degree | |
| Sentigen Biosciences, Inc. | Corporate Officer/Principal Private Equity Investor | ||
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree | |
| AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 34 |
| Canada | 13 |
| Royaume-Uni | 3 |
| France | 2 |
| Belgique | 2 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 18 |
| Finance | 5 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 535 |
| Corporate Officer/Principal | 273 |
| Independent Dir/Board Member | 124 |
| Undergraduate Degree | 80 |
| Chief Executive Officer | 78 |
Relations les plus connectées
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Myrtle Potter | 42 |
| Marie-Laure Jeanne Antoinette Pochon | 36 |
| Michael Rosenblatt | 31 |
| Caroline Dorsa | 27 |
| Mark Iwicki | 26 |
| Louis P. Lacasse | 26 |
| Ben Shapiro | 24 |
| Julian Adams | 23 |
| Stefan Oschmann | 23 |
| Philippe Schaison | 22 |
| John L. Zabriskie | 22 |
| R. Gordon Douglas | 21 |
| Kamil Ali-Jackson | 21 |
| Judy Lewent | 19 |
- Bourse
- Insiders
- John W. Gillard
- Connexions Sociétés
